What Researchers Did
Researchers drew blood from 31 patients before and after their 1st and 20th hyperbaric oxygen treatments to check for changes in platelets and blood cell counts.
What They Found
In this study of 31 patients getting repeated hyperbaric oxygen (HBO2) treatments at 2.2 ATA for 90 minutes each, the researchers found no evidence that 20 sessions caused adverse effects on platelet aggregation, platelet oxidative metabolism, red or white cell counts, or total antioxidant status of the plasma. Red cell counts, hematocrit, hemoglobin, platelet counts and plasma protein showed no effect of HBO2. Mean lymphocyte count was 38% higher after the 20th treatment, platelet protein content was 23% higher, and arachidonic acid-dependent platelet activation was 24% higher. Plasma lactate fell from 3.2 to 2.5 mmol/l by the end of the study. In smokers, the capacity for oxidative metabolism in platelets increased by the 20th treatment.
What This Means for Canadian Patients
The abstract says these treatments are used for chronically ill patients with problem wounds, and that there were concerns about oxygen's effect on blood cells and platelets. In this group of 31 patients, 20 sessions at 2.2 ATA did not produce adverse effects on the measures the researchers tracked. The abstract also reports some changes, such as higher lymphocyte counts and higher arachidonic acid-dependent platelet activation, and it does not say what these changes mean for patients.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract describes a single group of 31 patients with no comparison group that did not receive HBO2, so it cannot show that the changes seen were caused by the treatment, and only the 1st and 20th sessions were sampled.